Tenofovir in better shape for HAART-associated lipoatrophy

By  

Reactions Weekly, Vol. 1, Iss. 1048, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Intermittent HAART no better than continuous for QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Tenofovir-associated tubulopathy: what are the risk factors?

By  

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature

By Holstein Andreas   Stege Helger   Kovacs Peter  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Polyacrylamide Gel Injection for Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy: 18 Months Follow-Up

By RAUSO RAFFAELE   FREDA NICOLA   PARLATO VINCENZO   GHERARDINI GIULIO   AMORE ROBERTO   TARTARO GIANPAOLO  

Dermatologic Surgery, Vol. 37, Iss. 11, 2011-11 ,pp. : 1584-1589

Elsevier

Access to resources Recommend Favorite